1. Exploring the biofilm inhibitory potential of Candida sp. UFSJ7A glycolipid on siliconized latex catheters.
- Author
-
Bastos CG, Livio DF, de Oliveira MA, Meira HGR, Tarabal VS, Colares HC, Parreira AG, Chagas RCR, Speziali MG, da Silva JA, Granjeiro JM, Millán RDS, Gonçalves DB, and Granjeiro PA
- Subjects
- Latex chemistry, Latex pharmacology, Escherichia coli drug effects, Enterococcus faecalis drug effects, Enterococcus faecalis physiology, Candida albicans drug effects, Candida albicans physiology, Glycolipids pharmacology, Glycolipids chemistry, Biofilms drug effects, Biofilms growth & development, Surface-Active Agents pharmacology, Surface-Active Agents chemistry, Candida drug effects, Candida physiology, Catheters microbiology
- Abstract
Biosurfactants, sustainable alternatives to petrochemical surfactants, are gaining attention for their potential in medical applications. This study focuses on producing, purifying, and characterizing a glycolipid biosurfactant from Candida sp. UFSJ7A, particularly for its application in biofilm prevention on siliconized latex catheter surfaces. The glycolipid was extracted and characterized, revealing a critical micellar concentration (CMC) of 0.98 mg/mL, indicating its efficiency at low concentrations. Its composition, confirmed through Fourier transform infrared spectroscopy (FT-IR) and thin layer chromatography (TLC), identified it as an anionic biosurfactant with a significant ionic charge of -14.8 mV. This anionic nature contributes to its biofilm prevention capabilities. The glycolipid showed a high emulsification index (E
24 ) for toluene, gasoline, and soy oil and maintained stability under various pH and temperature conditions. Notably, its anti-adhesion activity against biofilms formed by Escherichia coli, Enterococcus faecalis, and Candida albicans was substantial. When siliconized latex catheter surfaces were preconditioned with 2 mg/mL of the glycolipid, biofilm formation was reduced by up to 97% for E. coli and C. albicans and 57% for E. faecalis. These results are particularly significant when compared to the efficacy of conventional surfactants like SDS, especially for E. coli and C. albicans. This study highlights glycolipids' potential as a biotechnological tool in reducing biofilm-associated infections on medical devices, demonstrating their promising applicability in healthcare settings., (© 2024. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.)- Published
- 2024
- Full Text
- View/download PDF